KK Sundrug

9989

Equity

ISIN JP3336600006 / Valor 258816

Tokyo Stock Exchange (2024-12-26)

JPY 3,956.00+0.13%

KK Sundrug
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

KK Sundrug operates a chain of drugstores in Japan, offering pharmaceuticals, health products, and daily necessities.

Summarized from source with an LLMView SourceSector: Consumer Services

Q1 2024 Revenue

KK Sundrug reported a revenue of 185.8 billion JPY for the first quarter of 2024. This marks a significant increase compared to the same quarter in the previous year, reflecting the company's strong market performance and effective sales strategies.

Q1 2024 Earnings

In the first quarter of 2024, KK Sundrug achieved earnings of 6.3 billion JPY. This is a notable improvement from the 5.3 billion JPY reported in Q1 2023, indicating a positive trend in the company's profitability.

Annual Revenue Growth

For the fiscal year 2024, KK Sundrug's total revenue reached 751.8 billion JPY. This represents a substantial growth from the 690.5 billion JPY recorded in 2023, showcasing the company's expanding market presence and successful business operations.

Annual Earnings Increase

KK Sundrug's earnings for the year 2024 were reported at 29.1 billion JPY, up from 25.7 billion JPY in 2023. This increase highlights the company's effective cost management and revenue generation capabilities over the past year.

Dividend Information

KK Sundrug announced a forward dividend yield of 2.97% for the year 2024, with a dividend per share of 114.00 JPY. This reflects the company's commitment to returning value to its shareholders through consistent and attractive dividend payouts.

Summarized from source with an LLMView Source

Key figures

-12.5%1Y

33.0%3Y

-0.60%5Y

Performance

23.4%1Y

23.8%3Y

25.9%5Y

Volatility